To investigate whether irradiated volume of pelvic active bone marrow (ACTBM) may predict decreased blood cells nadirs in anal cancer patients undergoing concurrent chemo-radiation.
Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation
Franco, Pierfrancesco
First
;Arcadipane, Francesca;Lesca, Adriana;Gallio, Elena;Mistrangelo, Massimiliano;Trino, Elisabetta;Cassoni, Paola;Arena, Vincenzo;Faletti, Riccardo;Morino, Mario;Ricardi, Umberto
Last
2018-01-01
Abstract
To investigate whether irradiated volume of pelvic active bone marrow (ACTBM) may predict decreased blood cells nadirs in anal cancer patients undergoing concurrent chemo-radiation.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Dose to Pelvic Bone Marrow Defined with FDG PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo radiation.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
1.48 MB
Formato
Adobe PDF
|
1.48 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
